Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / ADSs
-
Shares outstanding
-
592,878
-
Total 13F shares
-
486,218
-
Share change
-
+30,812
-
Total reported value
-
$2,605,000
-
Price per share
-
$5.34
-
Number of holders
-
10
-
Value change
-
+$130,260
-
Number of buys
-
6
-
Number of sells
-
1
Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) as of Q4 2017
As of 31 Dec 2017 Scinai Immunotherapeutics Ltd. - ADSs (BVXV) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 486,218 shares of stock of the company.
Largest 10 holders included Ibex Investors LLC, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, Vantage Investment Advisors, LLC, HighTower Advisors, LLC, Psagot Investment House Ltd., LADENBURG THALMANN FINANCIAL SERVICES INC., MORGAN STANLEY, WELLS FARGO & COMPANY/MN, and Calton & Associates, Inc..
This table shows 10 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.